<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Evaluating infectious disease forecasts in a cost-loss situation - Health AI Hub</title>
    <meta name="description" content="In order for epidemiological forecasts to be useful for decision-makers the forecasts need to be properly validated and evaluated. Although several metrics fore">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Evaluating infectious disease forecasts in a cost-loss situation</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2601.05921v1" target="_blank">2601.05921v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2026-01-09
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Philip Gerlee, Torbj√∂rn Lundh, Anna Saxne J√∂ud, Henrik Thor√©n
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> q-bio.QM
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.90 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2601.05921v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2601.05921v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">In order for epidemiological forecasts to be useful for decision-makers the forecasts need to be properly validated and evaluated. Although several metrics fore evaluation have been proposed and used none of them account for the potential costs and losses that the decision-maker faces. We have adapt...</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Medical/health related research</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>This paper provides a critical framework for evaluating the practical utility of epidemiological forecasting models, which increasingly leverage AI and machine learning techniques. While it doesn't introduce a new AI model, it offers a method to assess whether existing or future AI-driven infectious disease forecasts provide actual value (beyond statistical accuracy) to decision-makers in a cost-loss situation. This is crucial for guiding the development and deployment of medical AI applications in public health, ensuring they lead to improved outcomes and efficient resource use.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>See abstract for details</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>See paper for methodology</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>See abstract</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>Potential clinical applications</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>Not analyzed</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>Not analyzed</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">q-bio.QM</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">q-bio.QM</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">In order for epidemiological forecasts to be useful for decision-makers the forecasts need to be properly validated and evaluated. Although several metrics fore evaluation have been proposed and used none of them account for the potential costs and losses that the decision-maker faces. We have adapted a decision-theoretic framework to an epidemiological context which assigns a Value Score (VS) to each model by comparing the expected expense of the decision-maker when acting on the model forecast to the expected expense obtained from acting on historical event probabilities. The VS depends on the cost-loss ratio and a positive VS implies added value for the decision-maker whereas a negative VS means that historical event probabilities outperform the model forecasts. We apply this framework to a subset of model forecasts of influenza peak intensity from the FluSight Challenge and show that most models exhibit a positive VS for some range of cost-loss ratios. However, there is no clear relationship between the VS and the original ranking of the model forecasts obtained using a modified log score. This is in part explained by the fact that the VS is sensitive to over- vs. under-prediction, which is not the case for standard evaluation metrics. We believe that this type of context-sensitive evaluation will lead to improved utilisation of epidemiological forecasts by decision-makers.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>